SEC Form 5 · accession 0000899243-16-012453
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J Mahaffy
Officer — President and CEO · Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 1, 2016 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2015 | G | 20,000 | $0.00 | D | 918,787 | D | |
| Common StockF1 | holding | — | — | — | 1,000 | I | By son | |
| Common StockF1 | holding | — | — | — | 1,000 | I | By daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.